Travere Therapeutics (TVTX) to Present New FILSPARI Data at ASN Kidney Week 2026
gurufocus.com · 2026-10-02
On October 02, 2026, Travere Therapeutics Inc (NASDAQ: TVTX) announced it will present nine new studies, including five oral reports, at the American Society of
Read the full story at gurufocus.com →
Is TVTX undervalued? See TickrTrends' fair value analysis →